Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts

Montoro, Miguel; Gisbert, Javier P.; Mearin, Fermín; García Erce, José Antonio; Jericó, Carlos; Martín de Argila, Carlos; Cucala, Mercedes; Villanueva, Cándido; Aisa, Ángeles P.; Canelles, Pilar; Planella, Montserrat; Lanas, Ángel; García López, Santiago; Calvet, Xavier; Quintana, Manuel; Hervás, Antonio José; Alcedo, Javier; Murcia, Óscar; Bujanda, Luis

doi:10.3389/fmed.2022.903739

Resumen: Gastrointestinal (GI) bleeding is associated with considerable morbidity and mortality. Red blood cell (RBC) transfusion has long been the cornerstone of treatment for anemia due to GI bleeding. However, blood is not devoid of potential adverse effects, and it is also a precious resource, with limited supplies in blood banks. Nowadays, all patients should benefit from a patient blood management (PBM) program that aims to minimize blood loss, optimize hematopoiesis (mainly by using iron replacement therapy), maximize tolerance of anemia, and avoid unnecessary transfusions. Integration of PBM into healthcare management reduces patient mortality and morbidity and supports a restrictive RBC transfusion approach by reducing transfusion rates. The European Commission has outlined strategies to support hospitals with the implementation of PBM, but it is vital that these initiatives are translated into clinical practice. To help optimize management of anemia and iron deficiency in adults with acute or chronic GI bleeding, we developed a protocol under the auspices of the Spanish Association of Gastroenterology, in collaboration with healthcare professionals from 16 hospitals across Spain, including expert advice from different specialties involved in PBM strategies, such as internal medicine physicians, intensive care specialists, and hematologists. Recommendations include how to identify patients who have anemia (or iron deficiency) requiring oral/intravenous iron replacement therapy and/or RBC transfusion (using a restrictive approach to transfusion), and transfusing RBC units 1 unit at a time, with assessment of patients after each given unit (i.e., “don’t give two without review”). The advantages and limitations of oral versus intravenous iron and guidance on the safe and effective use of intravenous iron are also described. Implementation of a PBM strategy and clinical decision-making support, including early treatment of anemia with iron supplementation in patients with GI bleeding, may improve patient outcomes and lower hospital costs.
Idioma: Inglés
DOI: 10.3389/fmed.2022.903739
Año: 2022
Publicado en: Frontiers in Medicine 9 (2022), 90373 [16 pp]
ISSN: 2296-858X
Factor impacto JCR: 3.9 (2022)
Categ. JCR: MEDICINE, GENERAL & INTERNAL rank: 58 / 169 = 0.343 (2022) - Q2 - T2
Factor impacto CITESCORE: 3.6 - Medicine (Q2)

Factor impacto SCIMAGO: 0.926 - Medicine (miscellaneous) (Q1)

Tipo y forma: Review (Published version)
Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)

You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use. You may not use the material for commercial purposes.

Exportado de SIDERAL (2024-03-18-15:37:46)

Permalink:

Visitas y descargas

Este artículo se encuentra en las siguientes colecciones:
Articles > Artículos por área > Medicina

Back to search

Record created 2022-11-15, last modified 2024-03-19

Versión publicada:
PDF

Rate this document:

(Not yet reviewed)

Add to personal basket
Export as BibTeX, MARC, MARCXML, DC, EndNote, NLM, RefWorks

Universidad de Zaragoza Repository

Indications and hemoglobin thresholds for red blood cell transfusion and iron replacement in adults with gastrointestinal bleeding: An algorithm proposed by gastroenterologists and patient blood management experts